Custom made core-multishell nanocarriers

DendroPharm´s advanced DendroSol® technology significantly improves drug solubility and skin penetration. Our nanocarriers offer selective targeting of tumors and inflamed tissue. Please contact us for your custom made nanocarrier synthesis.

Diffusion cell tests for dermal delivery & tests for active compound release

DendroPharm offers the following services:
         - Artificial skin model
         - Nude mouse/nude rat model
         - Human skin model
         - Drug release studies
         - Development of HPLC methods

Formulation & drug development

Profit from our drug development experience. We coordinate all required steps from discovery towards a functioning and validated GMP production of your drug.

GMP contract manufacturing

DendroPharm GmbH offers contract manufacturing for clinical trial samples for semi-solids. We also offer stability studies with GMP-conform analytics. We are located in Berlin and have 800 m2 of cleanroom, laboratory, storage and production facilities.

Please contact us for more details including our Accelerator program.

DendroPharm is interested in collaborations with companies or academic research groups to develop new drugs and novel drug delivery systems.

DendroPharm GmbH, in collaboration with the University Medical Center of the Charité and Freie Universität Berlin, develops non-sedative, non-addictive painkillers in the "NanoOpiat" project. This project is funded by the European Union within the framework of EFRE funding.

DendroPharm is a member of the "Network for Pharma Solutions" NetPhaSol.

DendroPharm Company Videos

DendroPharm: Innovation in veterinary medicine
Business Model Canvas - Dendropharm

October 2017 | DendroPharm becomes member of the "Network for Pharma Solutions" (NetPhaSol, Germany). This cooperation network for drug development serves as a platform for research, development and marketing of new products, processes and services.

Dezember 2016 | DendroPharm wins the Innovation Award Berlin-Brandenburg.

September 2015 | TÜV-SÜD certifies the quality management system of DendroPharm according to ISO 9001:2008.

December 2014 | DendroPharm qualifies for inclusion in the BAFA program for a 20% subsidy for direct private investments from 10.000 €. If interested, please get in touch with the management.

Read more